Medical Research Finder

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Lymphomas

Navigation

Contents

BCL-6 as a therapeutic target for lymphoma
Leeman-Neill & Bhagat, 2018 Exp Opin Ther Targets 22: 143-152

References (Sources)

Acalabrutinib in mantle cell lymphoma
Kapoor & Ansell 2018 The Lancet 391: 633-634
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm,multicentre, phase 2 trial
Wang et al. 2018a The Lancet 391: 659-667
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis
Sun et al. 2018b THE ONCOLOGIST 23: 624-630
BCL6 as a therapeutic target for lymphoma
Leeman-Neill & Bhagat, 2018 Exp Opin Ther Targets 22: 143-152
Review
Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies
Witkowska et al. 2018 Exp Opin Invest Drugs 27: 171-177
Review
Lymphoma: immune evasion strategies
Upadhyay et al. 2015 Cancers 7: 736-62
Review
Marginal zone lymphomas: second most common lymphomas in older patients
Bron et al. 2019 Current Opinion in Oncology. 31(5): 386-393
Role of stem cell transplant in lymphoma in the era of new drugs
Benekou & Montoto 2017
The Highs and Lows of Immune-Checkpoint Blockade in Lymphoma
Ansell 2019a Cancer Immunology Research 7: 696
Review
Times Not to Forget Radiotherapy When Treating Patients With Lymphoma
Enke 2019
Review

AI Chat

5/29/2026

Chat with our artificial intelligence:

Links

Lymphoma - Wikipedia